Viewing Study NCT00660504

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2026-03-28 @ 9:28 AM
Study NCT ID: NCT00660504
Status: COMPLETED
Last Update Posted: 2014-07-18
First Post: 2008-04-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer
Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Extensive Disease-Small Cell Lung Cancer View